In vitro wound healing: Inhibition activity of insect‐derived mAb CO17‐1A in human colorectal cancer cell migration. Issue 4 (3rd March 2020)

• Record Type: Journal Article
• Authors: Park, Se Ra; Ko, Kisung; Lim, Sohee; Cha, So Yeon; Chung, Hyun Joo; Park, Soon Ju; Myung, Soon‐Chul; Kim, Mi Kyung
• Is Part Of: Entomological research. Volume 50:Issue 4(2020:Jul.)
• Page Start: 199
• Page End: 204
• Publication Date: 2020-03-03
• Subjects: baculovirus insect cell expression system -- CO17‐1A -- colorectal cancer -- insect‐derived mAb -- recombinant glycoprotein -- wound healing; Insects -- Korea -- Periodicals; Entomology -- Periodicals; 595.709519
• DOI: 10.1111/1748-5967.12425
• Languages: English
• ISSNs: 1738-2297

Abstract

Abstract: The monoclonal antibody (mAb) CO17‐1A specifically binds to the tumor‐associated cell surface glycoprotein GA733 in colorectal cancer cells. Thus, mAb CO17‐1A has the potential to act as an immune therapeutic protein against colorectal cancer. Recently, it was shown that the baculovirus insect cell expression system produces anti‐colorectal cancer mAb CO17‐1A. In this study, the colorectal cancer antibody mAb CO17‐1A fused to the endoplasmic reticulum (ER) retention signal sequence (KDEL), and the (mAb CO17‐1AK) was expressed in Spodoptera frugiperda Sf9 insect cells. The yield, cell cytotoxicity, and in vitro anti‐tumor activity of mAb CO17‐1AK were verified. Western blotting was performed to confirm that both heavy and light chains of mAb CO17‐1A were expressed in Sf9 insect cells. The insect‐derived mAb (mAb I ) CO17‐1A was purified using a protein G affinity column. An in vitro wound healing assay was conducted to determine the inhibition activity of mAb CO17‐1A during tumor cell migration, showing that mAb I CO17‐1AK was effective as mammalian‐derived mAb CO17‐1A (mAb M CO17‐1A). These results suggest that the insect cell expression system can produce and properly assemble mAbs that inhibit tumor cell migration.